Register Cart 0

Generic placeholder image

Current Cancer Drug Targets

Editor-in-Chief

ISSN (Print): 1568-0096
ISSN (Online): 1873-5576

Back Subscribe

Subject index to volume 3

Author(s): Bentham Science Publishers

Volume 4, Issue 1, 2004

Page: [107 - 110] Pages: 4

DOI: 10.2174/1568009043481650

Price: $65

Abstract

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

10

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Pharmacologic Evidence of Green Tea in Targeting Tyrosine Kinases
Current Reviews in Clinical and Experimental Pharmacology

Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Current Medicinal Chemistry

Anticancer Vitamin K3 Analogs: A Review
Anti-Cancer Agents in Medicinal Chemistry

Tyrosine Kinase Mutations in Human Cancer
Current Molecular Medicine

DNA Methylation in Colon Cancer: Challenges and Opportunities
Epigenetic Diagnosis & Therapy (Discontinued)

Radiolabelling of Ascorbic Acid: A New Clue to Clarify its Action as an Anticancer Agent?
Current Radiopharmaceuticals

The Therapeutic Potential of the Wnt Signaling Pathway in Bone Disorders
Current Molecular Pharmacology

In Silico Design of Phenylbenzamide Derivatives Coupled to Pyrimidines as Novel hnRNP K Ligands Against Cancer
Current Bioactive Compounds

Chemoprevention Gene Therapy (CGT) of Pancreatic Cancer Using Perillyl Alcohol and a Novel Chimeric Serotype Cancer Terminator Virus
Current Molecular Medicine

A Hemagglutinin from Northeast Red Beans with Immunomodulatory Activity and Anti-proliferative and Apoptosis-inducing Activities Toward Tumor Cells
Protein & Peptide Letters

Pharmacogenetics of the Cytochromes P450
Current Topics in Medicinal Chemistry

Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition
Current Cancer Drug Targets

The Changing Face of HDAC Inhibitor Depsipeptide
Current Cancer Drug Targets

New Immunosuppressants: Immunosuppression and Immunomodulation
Medicinal Chemistry Reviews - Online (Discontinued)

The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets

Alginate Based Nanocarriers for Drug Delivery Applications
Current Pharmaceutical Design

Antifolate Inhibitors of Thymidylate Synthase as Anticancer Drugs
Mini-Reviews in Medicinal Chemistry

Chitinases: Biomarkers for Human Diseases
Protein & Peptide Letters

Using NMR to Develop New Allosteric and Allo-Network Drugs
Current Drug Discovery Technologies

The Clinical Perspective on Value of 3D, Thin Slice T2-Weighted Images in 3T Pelvic MRI for Tumors
Current Medical Imaging

© 2025 Bentham Science Publishers | Privacy Policy